Search results
Results from the WOW.Com Content Network
TMA technology allows a clinical laboratory to perform nucleic acid test (NAT) assays for blood screening with fewer steps, less processing time, and faster results. It is used in molecular biology , forensics , and medicine for the rapid identification and diagnosis of pathogenic organisms.
In the decade of the 2000s, the two most common commercially available tests were the amplified mycobacterium tuberculosis direct test (MTD, Gen-Probe) and Amplicor (Roche Diagnostics). In 2007, a systematic review of NAAT by the NHS Health Technology Assessment Programme concluded that "NAAT test accuracy to be far superior when applied to ...
Gen-Probe was a company based in San Diego, in California, specializing in clinical diagnostics, blood screening, transplantation products and research products.. The company's molecular diagnostics products were used for diagnosis of infectious diseases, blood screening, analyzing blood transfusions for immune response, testing coagulation pathways, and organ transplantation viability.
The test may enable the diagnosis of TB in patients likely to be missed by traditional tests. [ 4 ] [ 5 ] According to the Centers for Disease Control and Prevention (CDC) in 2015, [ 6 ] the Xpert MTB/RIF test was "revolutionizing TB control by contributing to the rapid diagnosis of TB disease and drug resistance.
Roughly 7.5% of kindergarteners had parents or guardians who filed for an exemption for at least one vaccine in 2013. Ten years later, that number rose to more than 17.5% -- one of the highest in ...
A simple cheek swab test called CheekAge may be able to predict a person's increase in mortality risk, according to its developers. A noninvasive cheek swab test could help predict aging, risk of ...
In the past nucleic acid tests have mainly been used as a secondary test to confirm positive serological results. [3] However, as they become cheaper and more automated, they are increasingly becoming the primary tool for diagnostics and can also be use for monitoring of treatment of viral infected individuals t.
As chatter around the microbiome crescendos, Dr. Elsa Jungman is piloting a one-on-one approach with her consumers. The skin pharmacologist and founder of her eponymous skin care line, launched ...